FDA: Blood Pressure Medication Recalled Over Potential Cancer Risk

  • Pharmaceutical giant Aurobindo Pharma USA is recalling two lots of a blood pressure medication it makes after they were found to contain an impurity linked to an increased cancer risk, the U.S. Food and Drug Administration announced.
  • The tablets, which contain quinapril and hydrochlorothiazide, commonly used to treat hypertension, are being pulled off the shelf for containing high levels of nitrosamine.
  • The compound isn’t dangerous in low levels but can elevate risk of cancer if high amounts are taken over a long period of time.
Click to read full article Go back home

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.